(Q35827108)

10 August 2017

Levocetirizine has a longer duration of action on improving total nasal symptoms score than fexofenadine after single administration (English)

1 reference

10 August 2017

Friedrich Horak

1

1 reference

10 August 2017

Petra U Zieglmayer

2

1 reference

10 August 2017

R Zieglmayer

3

1 reference

10 August 2017

A Kavina

4

1 reference

10 August 2017

P Lemell

5

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 July 2005

1 reference

British Journal of Clinical Pharmacology

10 August 2017

1 reference

10 August 2017

60

1 reference

10 August 2017

1

1 reference

10 August 2017

24-31

1 reference

Comparative clinical efficacy, onset and duration of action of levocetirizine and desloratadine for symptoms of seasonal allergic rhinitis in subjects evaluated in the Environmental Exposure Unit (EEU).

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884902

Efficacy and safety profile of fexofenadine HCl: a unique therapeutic option in H1-receptor antagonist treatment

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884902

First do no harm: managing antihistamine impairment in patients with allergic rhinitis.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884902

A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884902

Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884902

Changes in daytime sleepiness, quality of life, and objective sleep patterns in seasonal allergic rhinitis: a controlled clinical trial

11 July 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2005.02377.X

H1 antagonists: receptor affinity versus selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2005.02377.X

Effects of fexofenadine and desloratadine on subjective and objective measures of nasal congestion in seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2005.02377.X

Controlled comparison of the efficacy and safety of cetirizine 10 mg o.d. and fexofenadine 120 mg o.d. in reducing symptoms of seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2005.02377.X

A direct comparison of the efficacy of antihistamines in SAR and PAR: randomised, placebo-controlled studies with levocetirizine and loratadine using an environmental exposure unit - the Vienna Challenge Chamber (VCC).

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884902

The cost of productivity losses associated with allergic rhinitis.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884902

New therapeutic approaches to the treatment of nasal allergy: Antiinflammatory effects of H1 receptor antagonists

24 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15963090

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1365-2125.2005.02377.X

1 reference

10 August 2017

1 reference

10 August 2017

PubMed publication ID

15963090

1 reference